Details for New Drug Application (NDA): 202994
✉ Email this page to a colleague
The generic ingredient in LARIN 24 FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 202994
Tradename: | LARIN 24 FE |
Applicant: | Novast Labs |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202994
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LARIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202994 | ANDA | Northstar Rx LLC | 16714-416 | 16714-416-01 | 1 BLISTER PACK in 1 PACKET (16714-416-01) / 1 KIT in 1 BLISTER PACK |
LARIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 202994 | ANDA | Northstar Rx LLC | 16714-416 | 16714-416-02 | 1 BLISTER PACK in 1 CARTON (16714-416-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.02MG;1MG | ||||
Approval Date: | Feb 18, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription